Future directions in CML

Timothy P. Hughes, MD, FRACP, FRCPA, MBBS, FAAHMS

Cancer Theme Leader at SAHMRI
Beat Cancer Professor, University of Adelaide
Consultant Haematologist in the Division of Haematology in the Royal Adelaide Hospital Chair of the International Chronic Myeloid Leukemia Foundation (iCMLf)
Fellow of the Australian Academy of Health and Medical Sciences (AAHMS)

Jump to:
Please wait...
Tim Hughes
Professor Timothy Hughes is the Cancer Theme Leader at SAHMRI; Beat Cancer Professor, University of Adelaide and Consultant Haematologist in the Division of Haematology in the Royal Adelaide Hospital. He is also Chair of the International Chronic Myeloid Leukemia Foundation (iCMLf); Fellow of the Australian Academy of Health and Medical Sciences (AAHMS). Professor Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. He has published over 280 papers and over 40,000 citations.
Scroll to top

Enter the serial number on your certificate to access the GET Weekend archive of the various lectures!

For medical enquiries please contact 1800 671 203 (ph.)
or medinfo.phauno@novartis.com (email)

Novartis Pharmaceuticals Australia Pty Limited. ABN: 18 004 244 160
54 Waterloo Road, Macquarie Park NSW 2113. AU-9334 May 2019